Sky9 Capital
  • About Us
  • Portfolio
  • Insights
  • VC 3.0
  • Team
  • Fellowship
  • News
  • LP Login
  • CN
Syntis Bio
Close
Syntis Bio
Biotechnology

Small intestine biology-based oral therapy development

Syntis Bio develops oral therapies that harness the small intestine’s unique biology to provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to the world’s most prevalent conditions.

website
info@sky9capital.com
Silicon Valley
200 Kansas St Ste 200, San Francisco
CA 94103
Singapore
350 Orchard Road #11-08, Suite 52, Shaw House
238868
Shanghai
Suite 1807, Tower 1, Raffles City Changning 1133 Changning Road, Changning District
200051

© 2025 All Rights Reserved